Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

295.52 -5.88 (-1.95%)
Streaming Delayed Price Updated: 2:42 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,224,103
Open 300.00
Bid (Size) 295.43 (2)
Ask (Size) 295.62 (1)
Prev. Close 301.40
Today's Range 294.56 - 302.60
52wk Range 193.11 - 314.00
Shares Outstanding N/A
Dividend Yield 1.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach... 
Via iCrowdNewswire
Veterinary Antibiotics Market Research Insight 2022| Key Players are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Ve
Via iCrowdNewswire
Exposures COVID-19

Performance

YTD
+8.76%
+8.76%
1 Month
-1.10%
-1.10%
3 Month
+21.19%
+21.19%
6 Month
+14.67%
+14.67%
1 Year
+51.14%
+51.14%

More News

Read More
Top-Rated Eli Lilly Nears Breakout After FDA Approves Its Next Potential Blockbuster
Via Investor's Business Daily
How Is The Market Feeling About Eli Lilly?
Via Benzinga
Why Eli Lilly' Shares Are Trading Higher Today
Via Benzinga
Eli Lilly's Olumiant Becomes First FDA Approved Immunomodulatory Treatment For COVID-19
Via Benzinga
Lilly's Tirzepatide Shows Up To 22.5% Weight Loss In New Phase 3 Readout
Via Benzinga
Eli Lilly Achieves 80% Jump In COVID-19 Therapy Sales, Revises FY22 Guidance
Via Benzinga
Five Ways To Play A Stock Market Reprieve
Via Investor's Business Daily
Check Out What Whales Are Doing With LLY
Via Benzinga
Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices
Via Benzinga
Amid Slowing Sales at Home, Innovent Biologics Stumbles Overseas
Via Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Via Benzinga
FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) for Hospitalized Patients with COVID-19
Via Benzinga
Heart Failure Treatment Offers Hope to Diabetics
Via FinancialNewsMedia
7 Biotech Stocks With Key Catalysts for May
Via InvestorPlace
This Company Is Reportedly Solving Bedroom Performance Issues Behind Closed Doors
Via Benzinga
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
Via Investor's Business Daily
Here's How Much $1000 Invested In Eli Lilly 10 Years Ago Would Be Worth Today
Via Benzinga
Eli Lilly Whale Trades For April 28
Via Benzinga
How is it going with the Big Biopharma Earnings Week?
Via Talk Markets
Peering Into Eli Lilly and Company's Recent Short Interest
Via Benzinga
A Tale of Tangles Chapter Three: The Desert Expanse
Via Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Via Benzinga
Eli Lilly Rallies On First-Quarter Beat And As Obesity Drug Cuts 20% Body Weight
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.